Altered sensitivity of deoxyadenosine-resistant mouse leukemia l1210 cells to various kinase inhibitors

Anticancer Research

Volumn 19, Issue 2 A, 1999, Pages 1021-1026

  Somerville, Lilla ^a   Cory, Joseph G ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

2 Aminopurine; Apoptosis; Cell cycle; Drug resistance; Mouse leukemia L1210 cells; PD98059; Serine threonine kinase inhibitors; Wortmannin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 AMINOPURINE; DEOXYADENOSINE; ENZYME INHIBITOR; PROTEIN P53; RIBONUCLEOTIDE REDUCTASE; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DRUG RESISTANCE; LEUKEMIA CELL; LEUKEMIA L 1210; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

2-AMINOPURINE; ANDROSTADIENES; ANIMALS; APOPTOSIS; DEOXYADENOSINES; DRUG RESISTANCE, NEOPLASM; FLAVONOIDS; G2 PHASE; LEUKEMIA L1210; MICE; MITOSIS; TUMOR CELLS, CULTURED;

EID: 0032995505     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lowe SW: Cancer therapy and p53. Curr Opin Oncol 7: 547-553, 1995.
2. Milas L, Stephens LC, Meyn RE: Relation of apoptosis to cancer therapy. In Vivo 8: 665-673, 1994.
3. Kerr JF, Winterford DM, Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.
4. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810, 1994.
5. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KMW, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han C-I, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T, Cai D: Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med 2: 985-991, 1996.
6. Carter GL, Cory JG: Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase. Adv Enzyme Regul 29: 123-129, 1989.
7. Carter GL, Thompson DP, Cory JG: Mechanisms of drug resistance to inhibitors directed at the individual subunits of ribonucleotide reductase. Cancer Commun 1: 13-20, 1989.
8. Cory JG, Cory AH, Long SD, Carter GL, Johnson CE: Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine. Cancer Res 52: 2000-2003, 1992.
9. Cory JG, He AWR, Cory AH: Deoxyadenosjne-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53. Anticancer Res 16: 3483-3490, 1996.
10. He AWR, Cory JG: p53-Independent anisomycin-induced G1 arrest and apoptosis in L1210 cell lines. Anticancer Res 18: 1-8, 1998.
11. Traganos F, Israel R, Seshadri R, Kirschenbaum S, Potmesil M: Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells. Cancer Res 45: 6273-6279, 1985.
12. Cory AH, Owen TC, Barltrop JA, Cory JG: Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3: 207-212, 1991.
13. Krishan A: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66: 188-193, 1975.
14. Harrington EA, Bennett MR, Fanidi A, Evan GI: c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. Embo J 13: 3286-3295, 1994.
15. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM: Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74: 823-832, 1993.
16. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD: Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262: 695-700, 1993.
17. Wathelet MG, Clauss IM, Paillard FC, Huez GA: Induction of G2 arrest and gene expression by 2-aminopurine in human U937 promonocyte-macrophage cells, Exp Cell Res 219: 442-448, 1995.
18. Palayoor ST, Macklis RM, Bump EA, Coleman CN: Modulation of radiation-induced apoptosis and G2/M block in murine T-lymphoma cells. Radiation Res 141: 235-243, 1995.
19. Yao R, Cooper GM: Requirement for phosphatidylinositol-3-kinase in the prevention of apoptosis by the nerve growth factor. Science 267: 2003-2005, 1995.
20. Arcaro A, Wymann MP: Wortmannin is a potent phosphatidlyinositol-3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses. Biochem J 296: 297-301, 1993.
21. Lukas J, Bartkova J, Bartek J: Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol 16: 6917-6925, 1996.
22. Waskiewicz AJ, Cooper JA: Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol 7: 798-805, 1995.
23. Dudley DT, Long P, Decker SJ, Alexander JB, Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92: 7686-7689, 1995.
24. Alessi DR, Cuenda A, Philip C, Dudley DT, Saltiel AR: PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494, 1995.
25. Kastan MB, Onyekwere O, Sidransky D, Vogetstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
26. 2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res 55: 1763-1773, 1995.
27. Arita D, Kambe M, Ishioka C, Kanamaru R: Induction of p53-independent apoptosis associated with G2/M arrest following DNA damage in human colon cancer cell lines. Jpn J Cancer Res 88: 39-43, 1997.
28. Han Z, Catterjee D, He D, Early J, Pantazis P, Wyche J, Hendrickson E: Evidence for a G2 checkpoint in p53-independent apoptosis induction by x-irradiation. Mol Cell Biol 15: 5849-5857, 1995.
29. Ling Y, El-Naggar A, Priebe W, Perez-Soler R: Cell cycle-dependent cytotoxicity G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol Pharmacol 49: 832-841, 1996.
30. Svensson B, Ekstrom PA, Edstrom A: Increased levels of mitogen-activated protein kinase (MAP-K) detected in the injured adult mouse sciatic nerve. Neuroscience Letters 200: 33-36, 1995.